Market Overview

8 Biggest Price Target Changes For Monday

Share:
  • Deutsche Bank raised the price target for Stanley Black & Decker, Inc. (NYSE: SWK) from $136 to $143. Stanley Black & Decker shares closed at $118.36 on Friday.
  • Bank of America cut the price target for Best Buy Co Inc (NYSE: BBY) from $70 to $50. Best Buy shares closed at $55.37 on Friday.
  • JP Morgan boosted Sherwin-Williams Co (NYSE: SHW) price target from $380 to $415. Sherwin-Williams shares closed at $386.00 on Friday.
  • Barclays lowered the price target for Emerson Electric Co. (NYSE: EMR) from $85 to $71. Emerson Electric shares closed at $60.44 on Friday.
  • Guggenheim raised SCANA Corporation (NYSE: SCG) price target from $49 to $51. SCANA shares closed at $50.98 on Friday.
  • Goldman Sachs lifted the price target for Orchard Therapeutics PLC - ADR (NASDAQ: ORTX) from $18 to $21. Orchard Therapeutics shares closed at $14.56 on Friday.
  • Deutsche Bank cut the price target on Illinois Tool Works Inc. (NYSE: ITW) from $133 to $125. Illinois Tool Works shares closed at $131.04 on Friday.
  • JP Morgan raised the price target for Genpact Limited (NYSE: G) from $30 to $32. Genpact shares closed at $27.40 on Friday.

Posted-In: Price Target ChangesPrice Target Intraday Update Analyst Ratings

 

Related Articles (BBY + EMR)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
FTVMorgan StanleyMaintains70.0
ROKMorgan StanleyMaintains142.0
WWEFBN SecuritiesUpgrades100.0
SWNCapital One FinancialUpgrades
AEISCowen & Co.Downgrades57.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Proteostasis Therapeutics Rallies On Genentech Licensing Agreement

Benzinga's Top Upgrades, Downgrades For December 17, 2018